课题基金 / 基金详情

项目摘要

项目成果

Beverly L. Davidson的其他基金

相似基金

相关文献

中文摘要
翻译
基因转移作为一种研究工具正变得越来越重要,并且也具有临床潜力。 基因转移载体核心(GTVC)为癌症带来了基因转移经验的专业知识 生物医学的其他领域。与来自不同领域的多名研究人员的互动 学科和经验与多种不同类型的组织允许交叉施肥的想法, 技术进步和载体技术的创新。GTVC提供 1)与主要研究者协商 2)新型载体的开发 3)重组腺病毒、腺相关病毒的纯化和浓缩制剂 (AAV)和逆转录病毒(包括慢病毒) 4)对生成的载体进行功能和纯度的协作检测,最后进行常规制备 5)重组报告病毒的标准细胞系、表达质粒和储备液 GTVC工作人员和调查人员在载体设计和生成的所有阶段都保持密切联系。 因此,GTVC既是基因转移研究的研究和开发设施, 常规病媒制剂服务设施
英文摘要
Gene transfer is becoming increasingly important as a research tool and has clinical potential as well. The Gene Transfer Vector Core (GTVC) brings expertise to cancer from gene transfer experience in multiple other areas of biomedicine. The interaction with multiple investigators from various disciplines and experience with multiple different types of tissues allows for cross-fertilization of ideas, technical advancements, and innovations in vector technologies. The GTVC provides 1) Consultation with the Principal Investigator 2) Development of novel vectors 3) Purified and concentrated preparations of recombinant adenovirus, adeno-associated virus (AAV), and retrovirus (including lentivirus) 4) Collaborative testing of vectors generated for function and purity, and finally routine preparation 5) Standard cell lines, expression plasmids, and stocks of recombinant reporter viruses GTVC staff and investigators are in close contact through all phases of vector design and generation. Thus, the GTVC serves as both a research and development facility for gene transfer studies, and a service facility for routine vector preparations
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PROJECT 3: MUCOPOLYSACCHARIDOSIS TYPE 1 (MPS1)
  • 批准号:
    10668620
  • 项目类别:
  • 资助金额:
    $106.93万
  • 财政年份:
    2023
  • 负责人:
    Beverly L. Davidson
  • 依托单位:
Therapeutic APOE2 overexpression for early Alzheimer's disease
  • 批准号:
    10404485
  • 项目类别:
  • 资助金额:
    $180.24万
  • 财政年份:
    2019
  • 负责人:
    Beverly L. Davidson
  • 依托单位:
Therapeutic APOE2 overexpression for early Alzheimer's disease
  • 批准号:
    9922393
  • 项目类别:
  • 资助金额:
    $132.15万
  • 财政年份:
    2019
  • 负责人:
    Beverly L. Davidson
  • 依托单位:
Supplemental Request: Therapeutic APOE2 overexpression for early Alzheimer's disease
  • 批准号:
    10596304
  • 项目类别:
  • 资助金额:
    $139.34万
  • 财政年份:
    2019
  • 负责人:
    Beverly L. Davidson
  • 依托单位:
海外基金